1. Home
  2. NPWR vs MXCT Comparison

NPWR vs MXCT Comparison

Compare NPWR & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NET Power Inc.

NPWR

NET Power Inc.

HOLD

Current Price

$1.23

Market Cap

137.0M

Sector

Energy

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

SELL

Current Price

$1.07

Market Cap

136.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NPWR
MXCT
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.0M
136.2M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
NPWR
MXCT
Price
$1.23
$1.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$2.85
★ $4.11
AVG Volume (30 Days)
★ 519.2K
331.4K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.24
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.29
$0.64
52 Week High
$5.20
$1.86

Technical Indicators

Market Signals
Indicator
NPWR
MXCT
Relative Strength Index (RSI) 25.91 33.83
Support Level N/A $0.98
Resistance Level $1.84 $1.16
Average True Range (ATR) 0.08 0.05
MACD -0.06 -0.01
Stochastic Oscillator 1.45 11.90

Price Performance

Historical Comparison
NPWR
MXCT

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. Its business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. The company has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: